Abstract.
Metallothioneins I+II (MT-I+II) are antioxidant, neuroprotective factors. We previously showed that MT-I+II deficiency during experimental autoimmune encephalomyelitis (EAE) leads to increased disease incidence and clinical symptoms. Moreover, the inflammatory response of macrophages and T cells, oxidative stress, and apoptotic cell death during EAE were increased by MT-I+II deficiency. We now show for the first time that demyelination and axonal damage are significantly increased in MT-I+II deficient mice during EAE. Furthermore, oligodendroglial regeneration, growth cone formation, and tissue repair including expression of trophic factors were significantly reduced in MT-I+II-deficient mice during EAE. Accordingly, MT-I+II have protective and regenerative roles in the brain.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Author information
Authors and Affiliations
Additional information
Received 31 October 2002; received after revision 23 November 2002; accepted 26 November 2002
RID="*"
ID="*"Corresponding author. M. Penkowa and C. Espejo contributed equally to this paper.
Rights and permissions
About this article
Cite this article
Penkowa, M., Espejo, C., Martínez-Cáceres, E. et al. Increased demyelination and axonal damage in metallothionein I+II-deficient mice during experimental autoimmune encephalomyelitis. CMLS, Cell. Mol. Life Sci. 60, 185–197 (2003). https://doi.org/10.1007/s000180300013
Issue Date:
DOI: https://doi.org/10.1007/s000180300013